Early Patient Clinical Studies

Acquire robust Proof-of-Concept (PoC) data for your targeted populations with the Covance Early Clinical Development (ECD) specialists. The very nature of PoC studies requires cultivation to tease out excellences. Capitalize on the extensive experience your Covance ECD team provides to transition your product from healthy volunteers into target patient populations.

Which candidates to choose?

Identify the most promising drug candidates in your portfolio for commercial approval and success during this critical time in development. Covance offers the insight and expertise to design and execute clinical studies that answer questions about your compound prior to pivotal phase III clinical studies.

An integrated package of services and global reach

Your Covance team is comprised of physicians, scientists, project managers, study managers and statisticians that are experts in the PoC phase of development. With clinical research experts located throughout  the United States and Europe, your ECD team has access to special or targeted populations and are ready to find answers to any research questions that may arise.